# Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp

> **NCT01836367** · PHASE1 · COMPLETED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 20 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Ingenol Mebutate 0.015%

## Key facts

- **NCT ID:** NCT01836367
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01836367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01836367, "Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01836367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*